CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-05 | Burstein Jennifer Director | Grant or award · Director Stock Option (Right to Buy) | +7,639 | 7,639 | ||
| 2024-06-05 | Smith Julie Director | Grant or award · Director Stock Option (Right to Buy) | +7,639 | 7,639 | ||
| 2024-06-05 | SMITH IAN F Director | Grant or award · Director Stock Option (Right to Buy) | +7,639 | 7,639 | ||
| 2024-06-05 | Menzel Garry E Director | Grant or award · Director Stock Option (Right to Buy) | +7,639 | 7,639 | ||
| 2024-06-05 | TZIANABOS ARTHUR Director | Grant or award · Director Stock Option (Right to Buy) | +7,639 | 7,639 | ||
| 2024-06-05 | LEVIN ARTHUR A Director | Grant or award · Director Stock Option (Right to Buy) | +7,639 | 7,639 | ||
| 2024-06-05 | Krainer Adrian R. Director | Grant or award · Director Stock Option (Right to Buy) | +7,639 | 7,639 | ||
| 2024-06-03 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +10,000 | $0.60 | $6K | 12,485 |
| 2024-06-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −9,897 | $15.21 | $151K | 2,588 |
| 2024-06-03 | Ticho Barry CHIEF MEDICAL OFFICER | Sale 10b5-1 | −103 | $15.78 | $2K | 2,485 |
| 2024-06-03 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 60,000 | ||
| 2024-05-20 | Nash Huw M. COO & CBO | Option exercise 10b5-1 | +50,000 | $0.40 | $20K | 50,000 |
| 2024-05-20 | Nash Huw M. COO & CBO | Sale 10b5-1 | −50,000 | $15.39 | $770K | 0 |
| 2024-05-20 | Nash Huw M. COO & CBO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −50,000 | 46,000 | ||
| 2024-05-20 | Kaye Edward M. MD CEO | Sale 10b5-1 | −39,686 | $15.39 | $611K | 29,664 |
| 2024-05-20 | Kaye Edward M. MD CEO | Sale 10b5-1 | −2,664 | $16.05 | $43K | 27,000 |
| 2024-05-20 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise 10b5-1 | +8,599 | $7.07 | $61K | 11,197 |
| 2024-05-20 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale 10b5-1 | −8,599 | $15.04 | $129K | 2,598 |
| 2024-05-20 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,599 | 25,801 | ||
| 2024-05-15 | Leggett Thomas Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +396,200 | 396,200 |
Page 16 of 24 · 461 trades